Maybe we haven't talked much about this, but I'll sneak it in because that's what I do.
What you just heard on the electronics side, the technology side, the biology side is lagging behind a little bit. You hear about pharma taking $1 billion to develop a drug. Well, of course, there's the clinical trial, but the R and D is very, very expensive and mostly because there's a lot of trial and error and guessing and playing around, and that's an expensive process. Synthetic biologists are trying to do the same thing that they can do now in electronics, to build your prototype quickly, and to build all sorts of weird things in test, and then put them through the pipeline in a much faster way. Again, they're trying to accelerate exponentially the development of whatever they're trying to do.